SIGNALING PATHWAYS REGULATED BY BRASSICACEAE EXTRACT INHIBIT THE FORMATION OF ADVANCED GLYCATED END PRODUCTS IN RAT BRAIN by Al-Malki, Abdulrahman L. et al.
Al-malki et al., Afr J Tradit Complement Altern Med. (2017) 14(2):234-240 
doi:10.21010/ajtcam.v14i2.25 
234 
 
SIGNALING PATHWAYS REGULATED BY BRASSICACEAE  EXTRACT  INHIBIT THE  
FORMATION OF ADVANCED GLYCATED END PRODUCTS IN RAT BRAIN.  
 
Abdulrahman L. Al-Malki1,2,3,Elie K. Barbour3,4, Huwait EA1,2,5 Said S. Moselhy1,2,3,6  Anas Hassan 
Saeed ALZahrani 7and  Taha A. Kumosani1,3,8. 
 
Department of Biochemistry, Faculty of Science, King Abdulaziz University (KAU), P.O Box 80203, 
Jeddah, Saudi Arabia. 2Bioactive Natural Products Research Group, KAU.3 Experimental Biochemistry 
Unit, King Fahd Medical Research Center, KAU. 4Agriculture Department, Faculty of Agricultural and 
Food Sciences, American University of Beirut, Beirut, Lebanon; Adjuncted to Biochemistry Department, 
Faculty of Science, KAU. 5Vitamin D Pharmacogenomics Research Group, King Abdulaziz University. 
6Department of Biochemistry, Faculty of Science, Ain Shams University. 7Medical Student,5th year, King 
Abdulaziz University. 8 Production of bioproducts for industrial applications Research Group, KAU. 
 
Corresponding author Email: alalmalki@kau.edu.sa 
 
 
Abstract 
 
Background: The goal of this study was identification signaling molecules mediated the formation of AGEs in brain of 
rats injected with CdCl2 and the role of camel whey proteins and Brassicaceae extract on formation of AGEs in brain. 
Methods: Ninety male rats were randomly grouped into five groups; Normal control (GpI) and the other rats (groups 
II-V) were received a single dose of cadmium chloride i.p (5 µg/kg/b.w) for induction of neurodegeneration. Rats in 
groups III-V were treated daily with whey protein (1g/kg b.w) or Brassicaceae extract (1mg/kg b.w) or combined 
respectively for 12 weeks.  
Results: It was found that whey protein combined with Brassicaceae extract   prevented the formation of AGEs and 
enhance the antioxidant activity compared with untreated group (p <0.001). Serum tumor necrosis factor (TNF-α) and 
interleukine (IL-6) levels were significantly decreased (p<0.01) in rats treated with whey protein and Brassicaceae 
extract   formation compared with untreated. The combined treatment showed a better impact than individual ones 
(p<0.001). The level of cAMP but not cGMP were lowered in combined treatment than individual (p<0.01). 
Conclusion, it can be postulated that Whey protein + Brassicaceae  extract  formation could have potential benefits in 
the prevention of the onset and progression of neuropathy in patients. 
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Introduction 
 
Signal transduction is involved in cell function [Agrawal etal., 2005], development [etal.,2003], differentiation 
[Alberti etal.,1998], apoptosis and cell death. Signaling molecules including hormones, neurotransmitters and growth 
factors involve binding to target receptors initiates a process of cascade and finally response [AL-Lawati etal.,2002]. 
The amplified signal is then propagated to the nucleus, resulting in induction or repression of gene expression [Ashour 
etal.,1999]. Oxidative damage are often related with path physiology of many diseases [Badr etal.,2011]. Signaling 
pathways including protein dependent kinases (PK) and secondary messenger as cAMP, cGMP, IP3 and calcium. 
Identification of these mediators are important rational of identification of pathogenesis and therapeutic protocol [Beg 
etal.,1986] 
Cadmium (Cd) is a toxic heavy metal, considered as a human carcinogen by National Toxicology Agency 
[Floweler ,2009]. Cadmium (Cd) has a long half-life due to its low rate of elimination from the body. Thus, long-term 
exposure to Cd will lead to toxicity due to its accumulation in different tissues as brains and  central nervous system 
(CNS). Cd can be taken by inhalation and cross the blood brain barrier (BBB) permeability [Satarug etal., 2010]. The 
previous study indicated the hepatic-toxic effect of Cd that was associated with oxidative stress and tissue damage. 
The primary neurodegenerative diseases lead to dementia and loss of concentration [Renugadevj and 
Miltonprabu,2009] In neurodegenerative disease, the early stages, characterized by his inability to acquire new 
memories and difficulty in recalling When late stage, it is diagnosed with behavior assessments. The symptoms of late 
stage include confusion, mood swings, language breakdown,  long-term memory loss, [Eldemerdash etal.,2004]. loss of 
body functions, leading to death.  
Although the mechanism of Cadmium is not yet been well documented as a result of the pathophysiology of 
Cadmium, several factors are reported to play a role as activation of NF-κB [Ebaid etal.,2005]. Activation of the renin–
angiotensin system, acceleration of oxidative stress, activation of specific kinase and subsequent formation of advanced 
glycation end products (AGEs) are major risk factors. As a result of the injection with CdCl2, increased overproduction 
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reactive oxygen species (ROS). These ROS results in the glycation of proteins which enhance the formation of AGE 
which accumulated in different tissues causing its damage.Previous studies reported that camel milk have beneficial 
role in  Cadmium toxicity and many other diseases. Therefore, using of camel milk is a useful addition to the insulin 
used for the treatment of type I diabetes [Eeg etal.,2008].Whey protein is believed to be the best available protein, 
when compared to other proteins . Due to its regulatory effect on the key enzymes that regulate glucose and glycogen 
metabolism. In addition to the fact that, whey protein contains all amino acids that are necessary for cell growth 
[Floyed etal.,1970]. Brassicaceae   extract  was traditionally used in treatment of colic disease, diarrhea, sedative  (13) .  
The potential anti oxidant  activity  of Brassicaceae   extract  are due to  their content of phenolic compounds 
(14). It was reported that water extracts of functional foods proved to have a potent antioxidant function. It was proved 
that, a correlation between serum levels of Brassicaceae extract and metabolic disease as diabetes. The signaling 
pathway is missing for this mechanism.   
The aim of this study was identification of signaling   molecules including secondary messenger as cAMP, 
cGMP. Secondly, evaluate the role of camel whey proteins and Brassicaceae extract on the signals mediated the 
formation of AGEs in CdCL2 induced neurodegeneration and the mechanism of its action in an experimental rat 
model.  
 
Materials and Methods 
 
Nine week-old (120±20g) male Albino rats (n=90) will be obtained from KFMRC, King Abdulaziz University 
(Jeddah). The animals will be housed in cages and foods and tap water were given ad libitum. Rats will be randomly 
grouped into control (Group I) (n=15), received a single dose of 0.1 mol/L citrate buffer. And the other rats (groups 2-
5, 75 rats) were received a single dose of injected with CdCl2  i.p, at dose of 5 µg/kg. Rats in group II were considered 
diabetic untreated. Rats in groups III-V were treated daily with whey protein (1g/ kg b.w) or Brassicaceae extract (1 
mg/kg b.w) or combined for 6 weeks. Animals were fasted overnight; blood was collected directly from the heart. 
Serum was used for the determination of glucose, glycated hemoglobin, advanced glycated end products (AGES), 
malondialdhyde, superoxide dismutase, total antioxidant activity, urea and creatinine, inflammatory cytokines as tumor 
necrosis factor (TNF-α) and interleukine (IL-6) levels will be determined by using ELISA kit . 
 
Biochemical analysis in brain tissues 
 
Brain tissue (0.1g) was homogenized in 2 ml phosphate buffer (pH 7.3) contain protease inhibitor. Samples 
were centrifuged at 12,000 rpm/10 minutes at 5°C. The filtrate was used for the determination of malondialldhyde 
(MDA), reduced glutathione (GSH), catalase, superoxide dismutase by using commercial kits from BIORAD 
(England), tumor necrosis factor, interleukine-1, and advanced glycated end products (AGEs) levels by using ELISA 
kits. Protein levels was determined by Foline reagent using a standard curve [Joseph etal.,1999]. The levels of IL-6 and 
TNF-α were determined by ELISA using the commercially available kits according to the instructions of the 
manufacturer. Signaling molecules including secondary messenger as cAMP, cGMP were determined. 
 
Assay of cAMP and cGMP. 
 
Guanosine 3,5-cyclic monophosphate (cGMP) and cAMP in tissues were determined by direct immunoassay 
Kit with sensitivity, 1~100 fmol /ug protein per assay, than the cGMP Direct Immunoassay Kit, from antibody 
Biovision company. The level expressed as fmol of cAMP while for cGMP as pmol quantities. 
 
 
Statistical analysis 
 
Statistical analysis will be done by SPSS using student's t-test. Value of P < 0.05 was considered as 
statistically significant. ANOVA test will be performed to correlate between different groups. 
 
Results 
 
Administration of rats with CdCl2 resulted in a significant increase in blood glucose levels in the diabetic 
group compared with the control group (p<0.001), while treatment with whey protein or Brassicaceae extract or 
combined resulted in a significance decrease in blood glucose compared with the untreated diabetic animals (p<0.05, 
table 1). As a result of diabetes, HbA1c was significantly increased (p<0.05) in the diabetic untreated group. Treatment 
of animals with Whey protein + Brassicaceae extract improves the two parameters (table 1). The Whey protein + 
Brassicaceae extract   exert hypoglycemic action but less potent than insulin (p<0.05). The antioxidant activities GSH 
reduced, catalase, SOD in brain of diabetic animals were significantly reduced as a result of CdCl2 injection. 
Supplementation of whey protein or Brassicaceae extract or combination resulted in a significant elevation in GSH 
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(p<0.05 for each) level and the activities of catalase and SOD (p<0.001, <0.01 and <0.05) respectively (table 1). 
Administration of combination resulted in better   decrease of MDA levels than individual ones (table 2).   
Figures (1, 2) showed that, serum aldolase reductase and total antioxidant activities were significantly 
decreased in diabetic arts compared with control ones (p<0.01 and 0.001) respectively. Whey protein or Brassicaceae 
extract or combined showed an elevation in these activities with dose dependent. The enhancement in insulin injection 
is better than combination (p<0.05). 
  Fig.3 showed that, both TNFα and IL-1 play an important role in the pathogenesis of diabetic neuropathy. As a 
result of CdCl2 injection the brain levels of TNF-α and IL-1 were significantly elevated (p<0.001) for each indicating a 
considerable level of inflammation compared with the normal control rats. Administration of whey protein or 
Brassicaceae extract or combined results in a significant reduction of these elevated levels (p<0.01. Whey protein + 
Brassicaceae extract supplementation resulted in a significant reduction of AGEs in a dose dependent manner as 
indicated in Figure3. Combination effect attenuated AGE production compared with individual treatment (p<0.001). 
 
Table 1: body weight, glucose and HbA1c levels in different groups. 
 Group 1 Group II Group III Group IV Group V 
Initial body weight( gm) 120.13±9.5 125.44±7 129.19±6 122±7.2 131.33±6.5 
Final body weight( gm) 199.5±8.2 150.8±7.2a 167.3±16.5a,b 165.52±8.9a,b 210±12.3a,b 
Glucose ( mg/dl) 92.78±0.45 275.35±1.45a 145.92±1.4a,b 137.71±1.23b 102.21±0.57a,b 
HbA1c( %) 5.54±0.41 8.42±0.34a 6.8±0.54 b 6.8±0.38 b 5. 8±0.52 b 
 
(a): p value significant versus control. 
(b) p value significant versus diabetic. 
 
Table 2: Serum and brain malondialdhyde (MDA) level and reduced glutathione (GSH), catalase, and superoxide 
dismutase (SOD) activity in brain of different groups (Mean ±S.D)  
Groups Serum 
MDA 
(µ mol /L) 
Brain 
MDA 
µmol/mg 
protein 
GSH 
µg /mg protein 
Catalase 
U/mg protein 
SOD 
U/mg protein 
Group I (n = 15) 
Range 
Mean ±S.D. 
 
 
24 - 15.6 
75 ± 12 
 
98-196 
66.7 ± 28 
 
 
104 – 546 
284 ±52 
 
992-2349 
1249 +140 
 
956 – 2623 
1545 +191 
Group II (n= 12) 
Range 
Mean ±S.E. 
p* value 
 
40- 89 
48 ± 5.9 
< 0.01 
 
190-261 
188 ± 37 
N. S. 
 
68.7-221.5 
123.6 ±19.3 
< 0.01 
 
109.5 – 642 
358 ±65 
<0.001 
 
453-1342 
760±78 
<0.001 
Group III (n = 13) 
Range 
Mean ± S.E. 
p* value 
 
33 –56 
31±12.2 
< 0.01 
 
149 – 213 
142 ± 32 
<0.001 
 
121 – 496 
259 ±50 
<0.001 
 
706 – 2002 
843 ±134 
<0.001 
 
876 -1987 
1021 ±163 
<0.001 
Group IV (n= 13) 
Range 
Mean ±S.E. 
p** value 
 
16 – 73.4 
33 ±2.7 
< 0.001 
 
136-261 
133± 25 
<0.001 
 
69.6- 213.9 
128±16.4 
p< 0.05 
 
456 -1632 
987 ±56 
<0.001 
 
962-1316 
836±53 
<0.001 
Group V (n= 14) 
Range 
Mean ±S.E. 
p** value 
22 – 73.4 
38 ±6.7 
< 0.001 
 
156-261 
121± 25 
N.S. 
 
69.6- 213.9 
128 ± 16.4 
p< 0.05 
 
546 -1756 
1112 ±86 
<0.001 
 
624-2116 
1233±153 
<0.001 
 
P* value, all groups vs control 
P** value, treated Vs untreated 
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Figure 1: Serum aldose reductase activity in all studied groups (Mean ±SD). 
 
 
Figure 2: Serum total antioxidant activity in all studied groups (Mean ±SD). 
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Figure 3: Brain tumor necrosis factor (TNF- α), interleukine-1, and advanced glycated end products (AGEs) levels 
 
 
 
 
 
Figure 4: Brain cAMP and cGMP levels (Mean ± SE) 
 
 
 Discussion 
 
Whey protein showed in suppression of nuclear factor kappa B (NF-κB) signaling, which is activated by TNF-
α or the receptor activator of NF-κB ligand. The present study demonstrated that the interference with the 
overproduction of ROS by Whey protein + Brassicaceae extract in the CdCl2 injected   rats . Whey protein + 
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Brassicaceae extract reduced normalized downstream effectors of vascular response to injury. In addition, the 
reduction of free radicals overproduction suggest an indirect AGE-inhibiting effect of Combination treatment. 
Our data suggested that part of the beneficial effect of Combination includes the disruption of the detrimental AGE-
RAGE-NFκB pathways. It was found that whey protein effectively protect brain from CdCl2-mediated protein 
glycation in vitro.Recent investigations suggested that Brassicaceae extract is an anti-inflammatory agent used 
frequently in Japanese traditional medicine, are also AGEs inhibitors [Ganong ,1997]. This is in accordance of our 
results which found that, Whey protein + Brassicaceae extract prevent the formation of AGEs and the inhibition 
neurodegenerations. 
In the present study combined treatment with Whey protein + Brassicaceae extract have a good glycemic 
index control than individual one. This is reflected by increase body weight of treated diabetic rats compared with 
untreated. 
The antioxidant capacity of combined treatment elevated significantly compared with untreated. This indicate 
the efficacy of these compounds in prevention of ROS production. The antioxidant property of whey protein [Hsu et 
al., 2006] and Brassicaceae extract [Kar and Mishra,1976] explained their role in improving antioxidant capacity and 
suppress ROS generation in diabetic rats [Lands etal.,1999 and Hamadeh,2000].   
The elevation of cGMP level in CdCl2 rats mediated the formation of AGEs was indicated its role in diabetic 
neuropathy. Combination lowered cGMP level but not cAMP level that indicate mediator specificity in its action.  
The present study clearly demonstrates that controlling CdCl2 and catalytic reactive oxygen scavenging are effective 
approach for the prevention of diabetic retinopathy. Combination whey protein + Brassicaceae extract    treatment is a 
paradigm natural food supplement with a broad spectrum of beneficial biochemical and cell biological effects, based on 
its ability to reduce the CdCl2 -induced ROS overproduction. Since Whey protein + Brassicaceae extract   has 
beneficial effects on other target tissues of diabetic angiopathy, this concept appears attractive for the prevention or 
delay of diabetic angiopathy. In conclusion, it can be postulated that Whey protein + Brassicaceae extract could have 
potential benefits in the prevention of the onset and progression of neuropathy in diabetic patients. 
 
Acknowledgment 
 
This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, 
under grant no. (RG-9-130-37). The authors, therefore, acknowledge with thanks DSR technical and financial support. 
 
 
Conflict of Interests: The authors declare that there is no conflict of interests regarding the publication of this paper. 
 
 
References 
 
1. Agrawal RP, Beniwall R, Sharma S, Kochar DK, Tuteja FC, Ghorui SK and Sahan MS (2005). Effect of raw 
camel milk in type I diabeteus: One year randomized study. Journal of Camel Practice and Research 12(1): 27-35. 
2. Agrawal RP, Swani SC, Beniwall R, Kochar DK,Sahani MS, Tuteja FC and Ghorui SK (2003) Effect of camel 
milk on glycaemic control, lipid profile and diabetes quality of life in type –1 diabetes: a randomised perspective 
controlled cross over study. India Journal of Animal Sciences 73 (10): 1105-1110. 
3. Alberti KG and Zimmet PZ (1998). Definition, diagnosis and classification of diabetes mellitus and its 
complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. 
Diabet Med 15: 539-553. 
4. Al-Lawati JA, Al Riyami AM, Mohammed AJ, Jousilahti P (2002). Increasing prevalence of diabetes mellitus in 
Oman. Diabet Med 19: 954-957. 
5. Ashour M, Salem S, Hassaneen H, EL-Gadban H, Elwan N, Awad A and Basu TK (1999). Antioxidant status and 
insulin dependent diabetes mellitus (IDDM). J Clin Biochem Nutr 26: 99-107. 
6. Badr G, Ebaid H, Mohany H (2011) Modulation of immune cell proliferation and chemotaxis towards CC 
chemokine ligands (CCL)-21 and CXC chemokine ligand (CXCL)-12 in un-denatured whey protein-treated mice. 
J nutrit Biochem,  In Press.  
7. Beg OU, Von Bahr-Lind Strom H, Zaidi ZH and Jornvall H (1986). A camel milk protein rich in half cystine. 
Primary structure assessment of variations, internal repeat patterns and relationship with neurophysin and other 
active polypeptides. European Journal of Biochemistry 5(1): 195-201. 
8. Fowler BA. Monitoring of human populations for early markers of cadmium toxicity; a review. Toxicol Appl 
Pharmacol 2009; 238: 294-300. 
9. Satarug S, Garrett SH, Sens MA, Sens DA. Cadmium, environmental exposure and health outcomes. Environ 
Health Perspect 2010; 118: 182-190. 
10. Renugadevi j, Miltonprabu S. Protective role of alpha tocopherol and ascorbic acid against cadmium induced 
neurotoxicity in rats. Int J Med Sci 2009; 2: 11-17. 
Al-malki et al., Afr J Tradit Complement Altern Med. (2017) 14(2):234-240 
doi:10.21010/ajtcam.v14i2.25 
240 
 
11. El-demerdash FM, Yousef MI, kedwany FS, Baghdadi HH. Cadmium-induced changes in lipid peroxidation, 
blood hematology, biochemical parameters and semen quality of male rats: Protective role of vitamin E and beta-
carotene. Food Chem Toxicol 2004; 42: 1563-1571. 
12. Ebaid H, Hassnein K and El-Feki M (2005). The un-denatured whey protein enhanced wound healing in mice. J 
Egyp Germ Soc 40(c): 2-27.  
13. Ebaid H, Badr G, Metwalli A. (2011). Immunoenhancing property of dietary un-denatured whey protein derived 
from three camel breeds. Submitted to Nutrition Research.  
14. Eeg-Olofsson K, Cederholm J, Nilsson PM (2008). Risk of cardiovascular disease and mortality in overweight and 
obese patients with type 2 diabetes: an observational study in 13,087 patients. Diabetologia 52: 65-73. 
15. Floyd JC, Fajans SS, Pek S, Thiffault CA, Knopf RF, Conn JW (1970). Synergistic effect of certain amino acid 
pairs upon insulin secretion in man. Diabetes 19:102-8. 
16. Ganong W (1997). Review of Medical Physiology, 18th ed. Stamford, CT: Appleton & Lange. 
17. Hamadeh RR (2000). Noncommunicable diseases among the Bahraini population: a review. East Mediator Health 
J 6: 1091-1097. 
18. Hsu WT, Tsai LY, Lin SK, Hsiao K and Chen BH (2006). Effects of diabetes duration and glycemic control on 
free radicals in children with type 1 diabetes mellitus. Ann Clin Lab Sci 36:174-8. 
19. Joseph P, Murthy KR, Nelson JL and Kulkrani AP (1999). Peroxidase: a novel pathway for chemical oxidation in 
human term placenta. Placenta 13: 545-554. 
20. Kar M and Mishra D (1976). Catalase, peroxidase and polyphenoloxidase activities during rice leaf senescence. 
Plant Physiol 57: 315-319. 
21. Lands LC, Grey VL and Smountas AA (1999). The effect of supplementation with A cysteine donor on muscular 
performance. J Appl Physiol 87: 1381-1385. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
